We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

By HospiMedica International staff writers
Posted on 11 Jul 2025

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. More...

Such injuries can lead to complications that may impact the patient’s health and recovery. The ability to visualize nerves during surgery is crucial for minimizing this risk. However, until now, effective methods for clearly identifying nerves during surgery have been limited. Researchers have now identified a safe and effective fluorescent imaging agent that can help surgeons see more clearly, thereby protecting nerves during surgeries.

The fluorescent imaging agent, developed by researchers at Vanderbilt University Medical Center (VUMC, Nashville, TN, USA), aims to enhance the visualization of nerves during surgery. This agent, a synthetic peptide-dye conjugate, was specifically designed for use in fluorescence-guided nerve imaging. Researchers focused on utilizing intravenous infusion of the imaging agent to illuminate the tissue during surgery. By using excitation light, surgeons can clearly visualize nerves and avoid damaging them. The agent is safe for human use and represents a major step forward in improving surgical outcomes. Clinical trials for this solution were conducted in collaboration with other institutions, with Phase 3 trials currently ongoing.

The findings published in Nature Communications indicate that the fluorescent agent is both safe and effective in human surgeries. The agent’s ability to illuminate nerves significantly aids in their protection during surgery. The findings highlight the agent's potential for widespread use in improving patient outcomes in head and neck surgery. Moving forward, the researchers plan to work toward securing approval from the Food and Drug Administration for broader clinical use. The hope is that this technology will become an integral part of surgical procedures, offering both safety and precision.

“Cancer is a surgical disease,” said Sarah Rohde, MD, MMHC, Division Chief of Head and Neck Surgery, VUMC. “Most cancers get surgery. Primarily, early-stage disease … is a cancer that can be taken out and cured with surgery. “[With fluorescence imaging,] you can see the cancer light up, which makes it easier to treat.”

Related Links:
VUMC


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.